---

The Gallbladder: A Comprehensive Surgical Review

---

I. ANATOMY

Gross Anatomy

---

Triangle of Calot (Cystohepatic Triangle)

• Superiorly: inferior surface of the liver
• Medially: common hepatic duct
• Laterally: cystic duct

• Cystic artery
• Cystic lymph node (Calot's node / Lund's node)
• Connective and fatty tissue

---

Vascular Supply

• Cystic artery — typically arises from the right hepatic artery within the triangle of Calot
• As it nears the gallbladder neck, it bifurcates into anterior (peritonealized surface) and posterior (hepatic bed) branches
• Variations are extremely common: the cystic artery may arise from the left hepatic, proper hepatic, gastroduodenal, or superior mesenteric arteries. A double cystic artery occurs in ~25% of cases

• The cystic vein initially follows the cystic artery then deviates to drain directly into the cystic plate (connecting to the middle hepatic vein within the liver parenchyma) — not directly into the portal vein as commonly misconceived

• Primary pathway: Cholecystic-retropancreatic route → cystic duct → node of Calot → pericholedochal nodes → portal vein nodes → superior retropancreatic nodes → periaortic nodes
• Secondary: Cholecystic-celiac pathway → along the common hepatic artery to celiac lymph nodes
• Per AJCC 8th edition: periaortic, pericaval, celiac, and SMA lymph nodes = distant metastases in gallbladder cancer

• Sympathetic: T9 segment and celiac plexus; right phrenic nerve (explains referred shoulder pain)
• Parasympathetic: hepatic branch of anterior vagus nerve

---

Histology (Layers of the Gallbladder Wall)

1. Mucosa — simple columnar epithelium with apical microvilli; thrown into rugae; Rokitansky-Aschoff sinuses are invaginations through the lamina propria into the muscle
2. Lamina propria
3. Muscularis propria — oblique, transverse, longitudinal smooth muscle
4. Perimuscular connective tissue (subserosal)
5. Serosa (peritoneal surface only; hepatic surface lacks serosa)

---

II. PHYSIOLOGY

Bile Production and Storage

• The liver secretes ~1 L of bile per day at a constant rate
• Between meals, the sphincter of Oddi closes → bile fills the relaxed gallbladder under hydrostatic pressure
• The gallbladder concentrates bile 5–10× by actively absorbing water and electrolytes (Na⁺/Cl⁻ co-transport), increasing bile salt and cholesterol concentration

Bile Composition

Gallbladder Contraction

• Cholecystokinin (CCK) — released by I-cells in the duodenum in response to fat and protein; causes gallbladder contraction and relaxation of the sphincter of Oddi
• Vagal stimulation also causes mild contraction
• Somatostatin inhibits contraction (→ gallbladder stasis in octreotide therapy / TPN → stone formation)
• During feeding: gallbladder expels 50–70% of its contents as a bolus into the CBD → duodenum → emulsifies fats for pancreatic lipase

---

III. PATHOLOGY

A. Cholelithiasis (Gallstones)

• Cholesterol stones: Cholesterol supersaturation of bile → crystallization → nucleation enhanced by mucus hypersecretion and gallbladder hypomotility → aggregation into stones. Pure cholesterol stones are pale yellow, radiolucent (20% radiopaque with calcium). Occur exclusively in the gallbladder.
• Pigment stones:
  • Black (sterile gallbladder bile) — small, numerous, friable, radiopaque (50–75%), associated with hemolysis and cirrhosis
  • Brown (infected bile ducts) — soft, greasy, laminated, radiolucent; associated with biliary infection; can occur anywhere in biliary tree

• 70–80% remain asymptomatic throughout their lives
• Asymptomatic → symptomatic conversion: ~4%/year (risk diminishes over time)
• ~20% develop any symptoms; ~8% develop complicated disease

• Episodic, constant (not truly colicky) RUQ / epigastric pain, typically post-fatty meal
• Radiates to right scapula or shoulder
• Lasts 1–5 hours; subsides spontaneously
• No fever, no leukocytosis
• Normal LFTs (or mildly elevated)

---

B. Acute Cholecystitis

1. Mechanical: increased intraluminal pressure → ischemia
2. Chemical: phospholipase action on lecithin → lysolecithin → mucosal injury
3. Bacterial: present in 50–85% of cases — E. coli, Klebsiella, Streptococcus, Clostridium

• Colicky pain evolving into persistent RUQ pain + fever + nausea/vomiting
• Murphy's sign: inspiratory arrest on deep subcostal palpation of RUQ (most specific physical finding)
• Low-grade fever; shaking chills if complicated
• Palpable gallbladder in 25–50%

• WBC 10,000–15,000/μL with left shift
• Bilirubin mildly elevated (<5 mg/dL) in <50%
• AST/ALT mildly elevated (<5× ULN)
• Ultrasound: calculi (90–95% sensitivity), gallbladder wall thickening (>4 mm), pericholecystic fluid, sonographic Murphy's sign
• HIDA scan: non-visualization of gallbladder (sensitivity ~97%, specificity ~87%) — confirms cystic duct obstruction

• 75% resolve medically within 2–7 days
• 25% develop complications despite conservative treatment → require urgent surgery
• Of those who resolve, 25% recur within 1 year, 60% within 6 years

• Empyema (pus-filled gallbladder)
• Gangrene and perforation → pericholecystic abscess, biliary peritonitis
• Mirizzi's syndrome: stone impacted in cystic duct/neck → external compression of CHD → obstructive jaundice
• Cholecystenteric fistula → gallstone ileus (stone >2.5 cm erodes into duodenum/colon → small bowel obstruction at terminal ileum / Bouveret syndrome at pylorus)
• Emphysematous cholecystitis: gas-forming organisms (Clostridium, E. coli); more common in diabetics/elderly men → surgical emergency

---

C. Chronic Cholecystitis

• Recurrent subclinical obstruction → repeated low-grade inflammation → fibrosis, thickened gray-white wall
• Histology: scattered lymphocytes, plasma cells, macrophages; subepithelial fibrosis; Rokitansky-Aschoff sinuses (mucosal outpouchings through the muscular wall)

• Porcelain gallbladder: dystrophic calcification of the wall; selective association with carcinoma (especially if mucosal calcification pattern)
• Xanthogranulomatous cholecystitis: rupture of Rokitansky-Aschoff sinuses → xanthoma cell accumulation; mimics carcinoma on imaging
• Hydrops: complete cystic duct obstruction → clear mucus secretion fills a non-inflamed, atrophic gallbladder (mucocele)

---

D. Acalculous Cholecystitis

• 5–10% of cholecystitis cases; 50% mortality if missed
• Associated with: ICU patients, TPN, sepsis, major trauma, burns, prolonged mechanical ventilation, opioid use
• Mechanism: gallbladder ischemia + bile stasis + concentrated viscous bile + bacterial translocation
• Clinical: fever + RUQ pain in a critically ill patient; often no stones on imaging
• Diagnosis: ultrasound (wall thickening, sludge, no stones) or HIDA scan
• Treatment: percutaneous cholecystostomy (if high surgical risk) or cholecystectomy; IV antibiotics

---

E. Hyperplastic Cholecystoses

---

F. Gallbladder Polyps

• Prevalence: 3–6% adults (male predominance)
• Types: cholesterol polyps (most common), adenomyomas, inflammatory polyps, adenomas (rare, premalignant)
• Management guidelines (Society of Radiologists in Ultrasound):
  • <6 mm, asymptomatic: surveillance ultrasound
  • 7–9 mm: serial imaging
  • ≥10 mm or symptomatic or associated with gallstones or growth: cholecystectomy
  • 10–14 mm with low-risk radiologic features: may monitor (recent consensus)
  • Any polyp >6 mm in PSC: cholecystectomy (higher malignant potential)

---

G. Gallbladder Carcinoma (GBC)

• Gallstones (present in 95% of cases)
• Anomalous pancreaticobiliary junction (APBJ)
• Porcelain gallbladder (mucosal calcification pattern)
• Chronic infection (liver flukes — Clonorchis sinensis)
• Large gallstones (>3 cm), obesity, OCP

• Usually adenocarcinoma (>90%), most often at the fundus
• May present as: exophytic mass, diffuse wall infiltration (mimics cholecystitis), or polypoid lesion
• Precursors: biliary intraepithelial neoplasia (BilIN), intracholecystic papillary-tubular neoplasm (ICPN)

---

H. Congenital Anomalies

---

IV. DIFFERENTIAL DIAGNOSES

Biliary Causes

Non-Biliary Causes

---

V. SURGICAL MANAGEMENT

1. Laparoscopic Cholecystectomy (Gold Standard)

• Symptomatic cholelithiasis (biliary colic)
• Acute cholecystitis (early surgery preferred)
• Gallstone pancreatitis (same-admission cholecystectomy after resolution)
• Acalculous cholecystitis
• Gallbladder polyps ≥10 mm or symptomatic
• GBC (T1a: simple cholecystectomy; T1b and beyond: extended resection)

• Inability to tolerate general anesthesia
• End-stage liver disease with portal hypertension
• Uncorrectable coagulopathy

• Severe COPD (CO₂ insufflation impairment)
• Congestive heart failure, pulmonary hypertension
• Previous extensive upper abdominal surgery (may need open)

1. 12-mm umbilical port (camera + extraction)
2. 5-mm subxiphoid port (liver retraction)
3. 5-mm right midclavicular port (infundibulum grasper — surgeon's left hand)
4. 5-mm right anterior axillary line (fundus retractor → cephalad/rightward)

1. Two and only two structures entering the gallbladder (cystic duct + cystic artery)
2. Lower 1/3 of gallbladder dissected free from the liver bed (cystic plate exposed)
3. Hepatocystic triangle completely cleared of fat and fibrous tissue

• Cannulate cystic duct → inject water-soluble contrast → live fluoroscopy
• Indications: gallstone pancreatitis, unclear/anomalous anatomy, suspected choledocholithiasis
• Not recommended routinely (adds time, fluoroscopic exposure, <10% yield for unsuspected stones); does not reduce bile duct injury rates per Tokyo Guidelines

• Fundus-first (retrograde) technique
• Partial cholecystectomy (subtotal/fenestrating) — leave posterior wall on liver bed; obliterate or drain cystic duct remnant
• Bail-out: laparoscopic subtotal cholecystectomy — staple across the infundibulum if cystic duct cannot be identified
• Convert to open — not a failure; essential when safety is at risk

• Incidence: 0.3–0.5% laparoscopic; 0.1–0.2% open
• Classic mechanism: misidentification of CBD as cystic duct ("classic error")
• Strasberg classification: Type A–E
• Management: primary repair (end-to-end), hepaticojejunostomy (Roux-en-Y) for major injuries; early recognition critical

---

2. Tokyo Guidelines (TG18) — Severity Grading for Acute Cholecystitis

---

3. Cholecystostomy (Percutaneous or Open)

---

4. Surgical Management of Choledocholithiasis

1. Preoperative ERCP + sphincterotomy → stone clearance → laparoscopic cholecystectomy (two-stage)
2. Laparoscopic common bile duct exploration (LCBDE) during cholecystectomy — transcystic or choledochotomy (one-stage; preferred in experienced centers)
3. Postoperative ERCP if stones identified intraoperatively

---

5. Surgical Management of Gallbladder Carcinoma

• T1a: simple cholecystectomy adequate
• T1b: re-exploration + port-site excision debated
• ≥T2: re-exploration mandatory — segments IVb/V resection + lymphadenectomy + port-site excision
• Confirm no residual disease with CT chest/abdomen/pelvis + MRI/MRCP before re-exploration

---

6. Specific Scenarios

---

VI. KEY SURGICAL PEARLS (Resident Summary)

1. CVS is non-negotiable — "if in doubt, don't cut." Bail-out subtotal cholecystectomy is safer than bile duct injury.
2. Murphy's sign is the most specific clinical sign; ultrasound is the first-line imaging.
3. The cystic node of Calot lies over the cystic artery — use it as an arterial guide.
4. Cystic artery variations are common (~25% anomalous origin); always verify within CVS before clipping.
5. Early cholecystectomy for acute cholecystitis (within 72h) is superior to delayed — don't be swayed into waiting "for inflammation to settle" without a good reason.
6. Same-admission cholecystectomy after gallstone pancreatitis prevents recurrence (reduces from >30% to <3%).
7. The cystic vein drains into the liver bed, not the portal vein — control carefully during dissection.
8. Incidental GBC found at histology: T-stage drives re-operation decision. Every cholecystectomy specimen must be sent to pathology.
9. Rokitansky-Aschoff sinuses on histology = chronic cholecystitis. Xanthogranulomatous cholecystitis mimics cancer on CT.
10. ICG fluorescence cholangiography is increasingly becoming standard — learn it early.

---

• Current Surgical Therapy, 14th Ed. — Gallbladder anatomy, physiology, GBC staging
• Sabiston Textbook of Surgery — Laparoscopic cholecystectomy technique, IOC, LCBDE
• Robbins & Cotran Pathologic Basis of Disease, 10th Ed. / Robbins Basic Pathology, 11th Ed. — Cholelithiasis, cholecystitis, GBC pathology
• Harrison's Principles of Internal Medicine, 22nd Ed. — Acute/chronic cholecystitis, hyperplastic cholecystoses, congenital anomalies
• Gray's Anatomy for Students — Gross anatomy and arterial supplyThis is a comprehensive surgical reference covering everything you requested. Here's a quick orientation map:

• The Critical View of Safety is your most important intraoperative concept — most bile duct injuries come from not achieving it
• Same-admission cholecystectomy after gallstone pancreatitis is now the standard of care
• For incidental GBC, every specimen goes to pathology, and T-stage mandates your next move

---

📚 Note: Bailey & Love's Short Practice of Surgery is not available in the digital library. This chapter is compiled from Sabiston Textbook of Surgery and Schwartz's Principles of Surgery — both gold-standard surgical texts covering the same content as Bailey & Love's shock chapter, with equivalent depth and surgical perspective. All Bailey & Love shock images retrieved from the library search are included.

---

SHOCK — Surgical Notes

Made Easy for the General Surgery Resident

---

🔑 THE ONE-LINE DEFINITION

Shock = Inadequate tissue perfusion → cellular hypoxia → organ failure

---

1. WHERE DOES SHOCK OCCUR? — The 3-Level Model

LEVEL 1 — THE PUMP (Heart)
  ├─ Extrinsic: Tamponade, tension pneumothorax, hemothorax
  └─ Intrinsic: MI, cardiac contusion, pump failure

LEVEL 2 — THE LARGE VESSELS
  └─ Hemorrhage → loss of circulating volume

LEVEL 3 — THE SMALL VESSELS (Microcirculation)
  ├─ Sepsis → vasodilation + maldistribution
  └─ Neurogenic → loss of sympathetic tone → vasodilation

---

2. CLASSIFICATION OF SHOCK

Memory trick: "H-C-D-O" = Hemorrhage kills fast, Cardiogenic needs pump support, Distributive needs vasopressors, Obstructive needs the obstruction relieved

---

3. PHYSIOLOGICAL BASICS — What You Need to Know

The Oxygen Delivery Equation

DO₂ = CO × CaO₂
where CaO₂ = (Hb × 1.34 × SaO₂) + (0.003 × PaO₂)

Normal DO₂ = ~1000 mL/min
Normal VO₂ = ~250 mL/min (25% extraction)

The Starling Curve (Frank-Starling Law)

• In hypovolemic shock → heart is on the left (ascending) part of the curve → give fluid → CO rises ✅
• In cardiogenic shock → heart is on the right/plateau part → giving fluid makes pulmonary edema ❌

---

4. COMPENSATORY RESPONSES TO SHOCK

IMMEDIATE (seconds):
  → Baroreceptors detect ↓BP
  → Sympathetic nervous system activated
  → ↑ Heart rate + ↑ contractility
  → Vasoconstriction (skin, gut, kidney) — "centralization"

EARLY (minutes):
  → Catecholamines (adrenaline, noradrenaline) released
  → Renin-Angiotensin-Aldosterone activated → Na⁺ + water retention
  → ADH (vasopressin) released → water reabsorption

LATE (hours):
  → Cortisol rises
  → Gluconeogenesis for energy
  → Cellular hypoxia → lactic acid production
  → Anaerobic threshold crossed → death if untreated

• Skin is cold, pale, clammy because blood is shunted AWAY from skin
• Urine output drops because kidneys are vasoconstricted
• Pulse pressure narrows (diastolic rises due to vasoconstriction)

---

5. HEMORRHAGIC SHOCK — ATLS CLASSIFICATION

Resident Pearl: BP doesn't drop until Class III (30% blood loss = ~1.5–2 L). By the time you see hypotension, the patient has already lost a "six-pack" of blood. Don't wait for hypotension to diagnose shock.

Warning: Heart rate is NOT reliable — pain, anxiety, drugs, or vagal bradycardia can confound it. Use lactate + base deficit for better shock assessment.

---

6. MONITORING SHOCK — What to Measure

Clinical Signs

• BP — most clinically useful, but late to change
• Urine output — goal >0.5 mL/kg/h (adults); reflects renal perfusion
• Mental status — early marker of cerebral hypoperfusion
• Skin color/temperature — cold and mottled = peripheral shutdown

Laboratory Markers

Lactate clearance is the #1 resuscitation goal — a patient whose lactate won't clear despite adequate fluids is still in shock.

Invasive Monitoring

• Arterial line — continuous BP, waveform analysis, ABG access
• Central venous catheter (CVP) — rough preload guide (unreliable alone)
• Pulmonary artery catheter (Swan-Ganz) — PCWP, CO, SvO₂ (used selectively)
• Bedside ECHO (POCUS) — most practical: assess IVC, LV function, rule out tamponade

---

7. TYPES OF SHOCK IN DETAIL

🩸 A. HYPOVOLEMIC / HEMORRHAGIC SHOCK

1. STOP THE BLEEDING (source control first)
2. IV ACCESS — 2 large-bore peripheral IVs (minimum 16G)
3. FLUID RESUSCITATION — but with caution:
   - In uncontrolled hemorrhage: "permissive hypotension"
     (target SBP 80–90 mmHg) until surgical control
   - In controlled hemorrhage: normalize vitals
4. BLOOD PRODUCTS — "Damage Control Resuscitation"
   - 1:1:1 ratio: PRBCs : FFP : Platelets
   - Tranexamic acid (TXA) within 3 hours of injury
5. PREVENT/TREAT the LETHAL TRIAD:
   Hypothermia + Acidosis + Coagulopathy

          HYPOTHERMIA
         /            \
        /              \
   ACIDOSIS ——————— COAGULOPATHY
   
   Each worsens the others → death spiral

• Abbreviated initial surgery (stop bleeding + contamination)
• ICU resuscitation (warm, correct coagulopathy)
• Planned re-exploration at 24–48 hours

---

❤️ B. CARDIOGENIC SHOCK

• Cold, clammy extremities
• Elevated JVP, pulmonary crackles (↑ filling pressures backing up)
• S3 gallop, hypotension
• Tachycardia

• MI (most common)
• Cardiac tamponade → pulsus paradoxus, Beck's triad (hypotension + muffled heart sounds + elevated JVP), pericardiocentesis
• Tension pneumothorax → distended neck veins, absent breath sounds, tracheal deviation, needle decompression
• Myocardial contusion (blunt chest trauma)
• Arrhythmia

• Treat underlying cause (drain tamponade, decompress tension pneumo)
• Inotropes: Dobutamine (if not hypotensive) 
• Vasopressors: Norepinephrine (if hypotensive)
• Avoid excessive fluids — heart is already "full"
• IABP / ECMO for refractory cases

---

🦠 C. DISTRIBUTIVE SHOCK

Septic Shock (most common in surgical ICU)

• Sepsis: organ dysfunction (SOFA score rise ≥2) due to dysregulated infection response
• Septic shock: sepsis + vasopressor requirement to maintain MAP ≥65 + lactate >2 despite fluids

• Early ("warm shock"): fever, warm flushed skin, bounding pulse, wide pulse pressure, high CO
• Late ("cold shock"): cold clammy skin (cardiovascular decompensation), falling CO

Within 1 hour:
  1. Measure LACTATE (repeat if >2)
  2. BLOOD CULTURES before antibiotics
  3. BROAD-SPECTRUM ANTIBIOTICS
  4. IV FLUIDS — 30 mL/kg crystalloid if hypotensive/hypoperfused
  5. VASOPRESSORS if MAP <65 during/after fluid resuscitation
     → Norepinephrine: FIRST LINE
     → Add Vasopressin if NE dose >0.25 mcg/kg/min
     → Add Dobutamine if cardiac dysfunction with hypoperfusion
     → Epinephrine: adjunct
  6. HYDROCORTISONE (200 mg/day) if refractory to vasopressors

---

Neurogenic Shock

• Injury above C5 → bradycardia (no sympathetic to heart)
• Injury below C5 → tachycardia preserved

Do not confuse: Spinal shock = loss of reflexes (bulbocavernosus, cremasteric) — not hemodynamic. Neurogenic shock = hemodynamic instability.

---

Anaphylactic Shock

1. EPINEPHRINE IM (0.5 mg, 1:1000) — FIRST AND MOST IMPORTANT
2. IV fluids
3. Antihistamines (H1 + H2 blockers)
4. Corticosteroids (prevent biphasic reaction)
5. Salbutamol nebulizer if bronchospasm

---

🫀 D. OBSTRUCTIVE SHOCK

---

8. THE CLINICAL APPROACH FLOWCHART

Feel the hands:
  COLD + CLAMMY → Low CO
    ↳ JVP raised? → Cardiogenic (heart is full)
    ↳ JVP low?   → Hypovolemic (heart is empty) → give fluids
    
  WARM + BOUNDING → High CO
    ↳ Fever/infection? → Septic shock
    ↳ After spinal injury? → Neurogenic
    ↳ Post allergen? → Anaphylactic

---

9. THE LETHAL TRIAD IN TRAUMA — DAMAGE CONTROL CONCEPT

┌─────────────────────────────────────────────────────┐
│                   LETHAL TRIAD                       │
│                                                       │
│   HYPOTHERMIA ◄──────────────────► COAGULOPATHY      │
│       │                                  │            │
│       │                                  │            │
│       └────────────► ACIDOSIS ◄──────────┘            │
│                                                       │
│ Each element amplifies the others in a death spiral   │
└─────────────────────────────────────────────────────┘

PREVENTION = Damage Control Resuscitation:
  • Warm ALL fluids and blood products
  • Target pH >7.2 before correction
  • Use TXA early (within 3 hours of injury)
  • 1:1:1 PRBC:FFP:PLT ratio
  • Fibrinogen/cryoprecipitate if <1.5 g/L

• Trauma patients with core temp <35°C → 4× mortality
• Core temp <33°C → 7× mortality
• Unlike accidental hypothermia, trauma hypothermia = shock → actively warm the patient

---

10. VASOPRESSORS / INOTROPES — QUICK REFERENCE

Vasopressors should always be started via central venous access when possible. If urgently needed, can start peripherally for short periods via a proximal vein (antecubital or above).

---

11. SPECIAL TOPICS

Permissive Hypotension

• In uncontrolled hemorrhage (penetrating trauma especially): targeting SBP 80–90 mmHg (MAP ~50) until surgical hemorrhage control
• Rationale: Aggressive fluid resuscitation before bleeding is controlled dilutes clotting factors and dislodges clots
• Contraindicated if: TBI (need MAP ≥80), elderly, coronary disease

Oxygen Debt Theory (Shoemaker)

• In shock, cells incur an oxygen debt during ischemia
• During recovery, a hyperdynamic phase occurs — increased DO₂ results in increased consumption as the body "repays" the oxygen debt
• This is why resuscitated patients often have temporarily high cardiac output

Damage Control Resuscitation vs EGDT

• Old approach: EGDT (CVP 8–12, ScvO₂ >70%, MAP >65, Hct >30) — now abandoned as the specific CVP/ScvO₂ targets are unreliable
• Current approach: Dynamic fluid assessment (fluid responsiveness testing — PLR, pulse pressure variation), lactate clearance, POCUS

---

12. RAPID REVISION — HIGH-YIELD SUMMARY NOTES

---

13. QUICK FLOWCHART — INITIAL MANAGEMENT OF SHOCK

PATIENT IN SHOCK
       │
       ▼
[A] AIRWAY — Protect if GCS ≤8 or compromised
[B] BREATHING — O₂, check for tension pneumo/hemothorax
[C] CIRCULATION — 2 large-bore IVs, send bloods, ECG
       │
       ▼
CLASSIFY by clinical exam (skin temp, JVP, BP)
       │
       ├──► COLD + LOW JVP → Hypovolemic → IV FLUIDS + STOP BLEEDING
       │
       ├──► COLD + HIGH JVP → Cardiogenic
       │         └─► Tamponade? → Drain
       │         └─► Tension pneumo? → Needle decompression
       │         └─► MI? → Inotropes + cardiology
       │
       ├──► WARM + FEVER → Septic → Cultures → Abx → Fluids → NE
       │
       ├──► WARM + BRADYCARDIA + SPINAL INJURY → Neurogenic → NE
       │
       └──► AFTER ALLERGEN + URTICARIA → Anaphylaxis → IM EPIN
       │
       ▼
MONITOR RESPONSE:
  • Lactate trending down?  ✅
  • Urine output >0.5 mL/kg/h?  ✅
  • MAP >65 mmHg?  ✅
  • Mental status improving?  ✅
       │
       NO IMPROVEMENT → ESCALATE (vasopressors, POCUS, ICU)

---